Establishment of novel neuroendocrine carcinoma patient-derived xenograft models for receptor peptide-targeted therapy

Authors

Catherine G Tran, University of Iowa Carver College of Medicine
Jacqueline L Mudd, Washington University School of Medicine in St. Louis
Ramaswamy Govindan, Washington University School of Medicine in St. Louis
Paul F Cliften, Washington University School of Medicine in St. Louis
Ryan C Fields, Washington University School of Medicine in St. Louis

Journal

Cancers

Publication Date

4-10-2022

Volume

14

Issue

8

First Page

1910

Document Type

Open Access Publication

DOI

10.3390/cancers14081910

Rights and Permissions

Tran, C.G.; Borbon, L.C.; Mudd, J.L.; Abusada, E.; AghaAmiri, S.; Ghosh, S.C.; Vargas, S.H.; Li, G.; Beyer, G.V.; McDonough, M.; Li, R.; Chan, C.H.F.; Walsh, S.A.; Wadas, T.J.; O’Dorisio, T.; O’Dorisio, M.S.; Govindan, R.; Cliften, P.F.; Azhdarinia, A.; Bellizzi, A.M.; Fields, R.C.; Howe, J.R.; Ear, P.H. Establishment of Novel Neuroendocrine Carcinoma Patient-Derived Xenograft Models for Receptor Peptide-Targeted Therapy. Cancers 2022, 14, 1910. doi.org/10.3390/cancers14081910 This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited

Recommended Citation

Tran, Catherine G; Mudd, Jacqueline L; Govindan, Ramaswamy; Cliften, Paul F; and Fields, Ryan C, "Establishment of novel neuroendocrine carcinoma patient-derived xenograft models for receptor peptide-targeted therapy." Cancers. 14, 8. 1910 (2022).
https://digitalcommons.wustl.edu/open_access_pubs/11720